Evidence map›Paper›PMID 25623068›Full record

ArticleThe Journal of biological chemistry2015

Ectopically expressed pro-group X secretory phospholipase A2 is proteolytically activated in mouse adrenal cells by furin-like proprotein convertases: implications for the regulation of adrenal steroidogenesis.

Joseph D Layne, Preetha Shridas, Nancy R Webb

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. sPLAScience advances · 2026
    Article
  2. Intestinal overexpression ofFrontiers in cellular and infection microbiology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. The Roles of the Secreted Phospholipase AAdvances in immunology · 2016
    Review
  7. Metabolic regulation by secreted phospholipase AInflammation and regeneration · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Joseph D LayneFrom the Department of Pharmacology and Nutritional Sciences, Division of Nutritional Sciences, the Saha Cardiovascular Research Center, and.
Preetha Shridasthe Department of Internal Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536.
Nancy R Webbthe Department of Internal Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536 nrwebb1@uky.edu.
University of Kentucky · US

Funding

TRAINING PROGRAM IN OXIDATIVE STRESS AND NUTRITIONT32DK007778 · NIDDK · UNIVERSITY OF KENTUCKY · PI WEBB, NANCY R · 2000 to 2019
$2.5M
Group X sPLA2: Regulator of Lipolysis and Glucose HomeostasisR01DK082419 · NIDDK · UNIVERSITY OF KENTUCKY · PI WEBB, NANCY R · 2009 to 2013
$1.6M
NIDDK NIH HHS 2T32DK007778-11NIDDK NIH HHS R01 DK082419NIDDK NIH HHS T32 DK007778
6 · The paper itself

Abstract

Group X secretory phospholipase A2 (GX sPLA2) hydrolyzes mammalian cell membranes, liberating free fatty acids and lysophospholipids. GX sPLA2 is produced as a pro-enzyme (pro-GX sPLA2) that contains an N-terminal 11-amino acid propeptide ending in a dibasic motif, suggesting cleavage by a furin-like proprotein convertase (PC). Although propeptide cleavage is clearly required for enzymatic activity, the protease(s) responsible for pro-GX sPLA2 activation have not been identified. We previously reported that GX sPLA2 negatively regulates adrenal glucocorticoid production, likely by suppressing liver X receptor-mediated activation of steroidogenic acute regulatory protein expression. In this study, using a FLAG epitope-tagged pro-GX sPLA2 expression construct (FLAG-pro-GX sPLA2), we determined that adrenocorticotropic hormone (ACTH) enhanced FLAG-pro-GX sPLA2 processing and phospholipase activity secreted by Y1 adrenal cells. ACTH increased the expression of furin and PCSK6, but not other members of the PC family, in Y1 cells. Overexpression of furin and PCSK6 in HEK 293 cells significantly enhanced FLAG-pro-GX sPLA2 processing, whereas siRNA-mediated knockdown of both PCs almost completely abolished FLAG-pro-GX sPLA2 processing in Y1 cells. Expression of either furin or PCSK6 enhanced the ability of GX sPLA2 to suppress liver X receptor reporter activity. The PC inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethyl ketone significantly suppressed FLAG-pro-GX sPLA2 processing and sPLA2 activity in Y1 cells, and it significantly attenuated GX sPLA2-dependent inhibition of steroidogenic acute regulatory protein expression and progesterone production. These findings provide strong evidence that pro-GX sPLA2 is a substrate for furin and PCSK6 proteolytic processing and define a novel mechanism for regulating corticosteroid production in adrenal cells.

Indexed as

Adrenal GlandsAdrenocorticotropic HormoneAnimalsBase SequenceDNA PrimersEnzyme ActivationFurinMicePhospholipases A2, SecretoryPolymerase Chain ReactionProprotein ConvertasesProteolysisSteroidsAdrenocorticotropic HormoneDNA PrimersFurinPhospholipases A2, SecretoryProprotein ConvertasesSteroidsAdrenalGlucocorticoidNuclear ReceptorPhospholipaseProprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

Identifiers

PMID25623068
PMCPMC4367284
OpenAlexW2052299108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.